Advances in amyloid beta oligomer detection applications in Alzheimer's disease
Authors:
- Angelo JamerlanAJAngelo Jamerlan
- Seong Soo A. AnSASeong Soo A. An
- John HulmeJHJohn Hulme
- 1 August 2020
- journal article
- review article
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 129
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Gachon University (2017R1A2B4012636)
- Gachon University (2019-0357)
This publication has 135 references indexed in Scilit:
- Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studiesClinical and Translational Imaging, 2013
- Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s DiseasePLOS ONE, 2013
- Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flowScientific Reports, 2013
- Surface Plasmon Resonance Imaging of Amyloid-β Aggregation Kinetics in the Presence of Epigallocatechin Gallate and MetalsAnalytical Chemistry, 2012
- Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of ToxicityJournal of Molecular Biology, 2012
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Amyloid Imaging with18F-Florbetaben in Alzheimer Disease and Other DementiasJournal of Nuclear Medicine, 2011
- Amyloid-beta oligomers increase the localization of prion protein at the cell surfaceJournal of Neurochemistry, 2011
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection SystemBiochemical and Biophysical Research Communications, 2010